Physician profile
Ignacio Tapia
NPI 1871786756
$556.52
in general payments reported to CMS, 2019-2025
12 companies · $210 in 2025
The $210 reported for 2025 was more than what a typical Pediatric Pulmonology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $45.92 · 2024: $301 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $556.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $106.00 | 2024 | |
| Philips North America LLC | $93.89 | 2024-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Mallinckrodt Hospital Products INC. | $70.85 | 2024 | Inomax |
| Baxter Healthcare | $50.00 | 2024-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Synclara Cough System |
| Harmony Biosciences LLC | $47.62 | 2024 | |
| Aimmune Therapeutics, INC. | $39.60 | 2025 | Zenpep |
| Amgen INC. | $33.11 | 2025 | Tezspire |
| Nestle Healthcare Nutrition INC. | $28.89 | 2023 | |
| Alcresta Therapeutics, INC. | $25.42 | 2024 | Relizorb |
| Vertex Pharmaceuticals Incorporated | $24.35 | 2025 | |
| Insmed, INC. | $19.76 | 2025 | Brinsupri |
| Mylan Specialty L.P. | $17.03 | 2023 | Tobi Podhaler |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ignacio Tapia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.